| MYBBP1A |
MYBBP1A, P160: Myb-binding protein 1A |
APEX2 |
APEX2, APE2, APEXL2, XTH2: DNA-(apurinic or apyrimidinic site) lyase 2 |
0.253 |
Evidence |
|
| CCNF |
CCNF: G2/mitotic-specific cyclin-F |
FZR1 |
IPI00099464 |
0.253 |
Evidence |
|
| PDHX |
PDHX, PDX1: Pyruvate dehydrogenase protein X component, mitochondrial precursor |
DLAT |
Dihydrolipoamide S-acetyltransferase (Fragment) |
0.253 |
Evidence |
|
| WRN |
WRN, RECQ3, RECQL2: Werner syndrome ATP-dependent helicase |
APEX2 |
APEX2, APE2, APEXL2, XTH2: DNA-(apurinic or apyrimidinic site) lyase 2 |
0.253 |
Evidence |
|
| CDK2 |
CDK2: Cell division protein kinase 2 |
JARID2 |
JARID2, JMJ: Protein Jumonji |
0.253 |
Evidence |
|
| MDN1 |
MDN1, KIAA0301: Midasin |
PHF11 |
RP11-185C18.3, PHF11, RP11-185C18.3-001, hCG_28346: OTTHUMP00000018414 |
0.253 |
Evidence |
|
| DDX3X |
DDX3X, DBX, DDX3: ATP-dependent RNA helicase DDX3X |
CKS2 |
CKS2: Cyclin-dependent kinases regulatory subunit 2 |
0.253 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
CKS1B |
CKS1B, CKS1, PNAS-16, PNAS-143: Cyclin-dependent kinases regulatory subunit 1 |
0.253 |
Evidence |
|
| RPL18A |
RPL18A: 60S ribosomal protein L18a |
NSD1 |
NSD1, ARA267: Histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 |
0.253 |
Evidence |
|
| BIRC1 |
BIRC1, NAIP: Baculoviral IAP repeat-containing protein 1 |
EIF2B1 |
EIF2B1, EIF2BA: Translation initiation factor eIF-2B subunit alpha |
0.253 |
Evidence |
|
| SH3GL3 |
IPI00216202 |
DNALI1 |
DNALI1: Axonemal dynein light intermediate polypeptide 1 |
0.253 |
Evidence |
|
| RPS5 |
RPS5: 40S ribosomal protein S5 |
VDAC3 |
VDAC3: Voltage-dependent anion-selective channel protein 3 |
0.253 |
Evidence |
|
| HPN |
HPN, TMPRSS1: Serine protease hepsin |
MBL2 |
MBL2, MBL: Mannose-binding protein C precursor |
0.25 |
Evidence |
|
| F9 |
F9: Coagulation factor IX precursor |
C9 |
C9: Complement component C9 precursor [Contains: Complement component C9a; Compl |
0.25 |
Evidence |
|
| LPA |
LPA: Apolipoprotein(a) precursor |
MBL2 |
MBL2, MBL: Mannose-binding protein C precursor |
0.25 |
Evidence |
|
| F10 |
F10: Coagulation factor X precursor |
FGB |
FGB: Fibrinogen beta chain precursor [Contains: Fibrinopeptide B] |
0.25 |
Evidence |
|
| SRF |
SRF: Serum response factor |
HIF1A |
HIF1A, MOP1: Hypoxia-inducible factor 1 alpha |
0.25 |
Evidence |
|
| PLG |
PLG: Plasminogen precursor |
C9 |
C9: Complement component C9 precursor [Contains: Complement component C9a; Compl |
0.25 |
Evidence |
|
| TP53 |
TP53, P53: Cellular tumor antigen p53 |
DAXX |
DAXX, BING2, DAP6: Death domain-associated protein 6 |
0.25 |
Evidence |
|
| CCL16 |
CCL16, ILINCK, NCC4, SCYA16: Small-inducible cytokine A16 precursor |
HCRTR1 |
HCRTR1: Orexin receptor type 1 |
0.25 |
Evidence |
|
| CXCL10 |
CXCL10, INP10, SCYB10: Small-inducible cytokine B10 precursor |
GPR77 |
GPR77, C5L2: C5a anaphylatoxin chemotactic receptor C5L2 |
0.25 |
Evidence |
|
| ARL3 |
ARL3, ARFL3: ADP-ribosylation factor-like protein 3 |
GPR77 |
GPR77, C5L2: C5a anaphylatoxin chemotactic receptor C5L2 |
0.25 |
Evidence |
|
| TEP1 |
TEP1, TLP1, TP1: Telomerase protein component 1 |
IFIH1 |
IFIH1, MDA5, RH116: Interferon-induced helicase C domain-containing protein 1 |
0.25 |
Evidence |
|
| OR6A2 |
OR6A2, OR6A1, OR6A2P: Olfactory receptor 6A2 |
CXCL9 |
CXCL9, CMK, MIG, SCYB9: Small-inducible cytokine B9 precursor |
0.25 |
Evidence |
|
| FSHR |
FSHR, LGR1: Follicle-stimulating hormone receptor precursor |
CCL23 |
MIP3, CCL23, MPIF1, SCYA23: Small-inducible cytokine A23 precursor |
0.25 |
Evidence |
|